1. Home
  2. SNX vs INM Comparison

SNX vs INM Comparison

Compare SNX & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNX
  • INM
  • Stock Information
  • Founded
  • SNX 1980
  • INM 1981
  • Country
  • SNX United States
  • INM Canada
  • Employees
  • SNX N/A
  • INM N/A
  • Industry
  • SNX Retail: Computer Software & Peripheral Equipment
  • INM Biotechnology: Pharmaceutical Preparations
  • Sector
  • SNX Technology
  • INM Health Care
  • Exchange
  • SNX Nasdaq
  • INM Nasdaq
  • Market Cap
  • SNX N/A
  • INM 3.2M
  • IPO Year
  • SNX 2003
  • INM N/A
  • Fundamental
  • Price
  • SNX $111.07
  • INM $3.00
  • Analyst Decision
  • SNX Strong Buy
  • INM
  • Analyst Count
  • SNX 9
  • INM 0
  • Target Price
  • SNX $137.22
  • INM N/A
  • AVG Volume (30 Days)
  • SNX 1.4M
  • INM 56.6K
  • Earning Date
  • SNX 06-24-2025
  • INM 05-13-2025
  • Dividend Yield
  • SNX 1.58%
  • INM N/A
  • EPS Growth
  • SNX 16.43
  • INM N/A
  • EPS
  • SNX 8.00
  • INM N/A
  • Revenue
  • SNX $59,008,890,000.00
  • INM $4,832,013.00
  • Revenue This Year
  • SNX $3.20
  • INM N/A
  • Revenue Next Year
  • SNX $4.26
  • INM N/A
  • P/E Ratio
  • SNX $13.89
  • INM N/A
  • Revenue Growth
  • SNX 4.62
  • INM N/A
  • 52 Week Low
  • SNX $92.23
  • INM $1.72
  • 52 Week High
  • SNX $145.10
  • INM $15.70
  • Technical
  • Relative Strength Index (RSI)
  • SNX 51.09
  • INM 62.76
  • Support Level
  • SNX $102.16
  • INM $2.56
  • Resistance Level
  • SNX $110.77
  • INM $3.05
  • Average True Range (ATR)
  • SNX 4.40
  • INM 0.27
  • MACD
  • SNX 2.06
  • INM 0.09
  • Stochastic Oscillator
  • SNX 98.59
  • INM 92.98

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

Share on Social Networks: